Invex Therapeutics Company
Invex is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment.
Employee Number:
1-10
Funding Status:
IPO
Headquarters:
Subiaco, Western Australia, Australia
Technology:
Drug Delivery
Founded Date:
2019
Industry:
PharmTech